Kentucky providers with prescriptive authority take note: beginning June 29, 2017, new laws (HB 333) go into effect that significantly impact the prescribing of Schedule II drugs. Schedule II drugs include brand names such as Demerol, OxyContin and Percocet. Read More ›
In many states, an investigation into a healthcare provider’s license by the Department of Health may begin with a phone call, letter, or in-person meeting between a healthcare provider and a Department of Health investigator. While all individuals have a right to have an attorney present at an interview with a Department of Health investigator, most individuals may not realize they have this right until after the interview has passed. Which may leave you asking: what now? Read More ›
What You Should Know Before You Agree to Licensure Discipline: Is It Reportable to the National Practitioner Data Bank?
The National Practitioner Data Bank, or NPDB, is a repository of information created by the federal government to provide a comprehensive review of the professional credentials of health care practitioners, including, but not limited to, any discipline a health care practitioner receives from a state medical board. Read More ›
Ohio’s medical marijuana regulations are budding. Ohio recently released proposed rules for cultivators, those interested in “growing, harvesting, packaging, and transporting medical marijuana.” Read More ›
On December 15, 2016, the Ohio Board of Pharmacy posted its proposed rules governing the operation of medical marijuana dispensaries. The same day, the State Medical Board posted its proposed rules regulating the issuance of certificates to physicians wishing to recommend medical marijuana to their patients. Below are a few key points from each set of proposed rules. Read More ›
“Let’s get together and feel alright” sang the Ohio legislature to those suffering from ailments like: Alzheimer’s disease, Epilepsy, Fibromyalgia, and Parkinson’s disease. Those are just a few of the “qualifying medical conditions”1 in House Bill 523 for which a physician may prescribe medical marijuana. Read More ›
Ask the Blogger
Do you have a topic that you would like discussed in a future blog article? Please let us know. If you have a confidential question regarding a blog article, please feel free to contact the article's author directly, or let us know if you would like for someone to contact you directly.
Brian F. Higgins is an associate in FBT's regulated business group with a focus on health care, and he has a history as corporate counsel to Medpace, Inc., a pharmaceutical clinical research organization.